HF
PDLI

HRT Financial’s PDL BioPharma, Inc. PDLI Stock Holding History

HRT Financial’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-57,533
Closed -$181K – 2846
2020
Q3 		$181K Buy
+57,533
New +$184K 0.01% 1396
2017
Q3 		– Sell
-14,205
Closed -$35K – 152
2017
Q2 		$35K Buy
+14,205
New +$32.7K 0.06% 77

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

HRT Financial's PDLI Position: Q4 2020 in Review

HRT Financial sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 57,533 shares — an estimated $181K sold.

HRT Financial first reported a position in PDLI in Q2 2017 and held it in 2 quarters. The position peaked at $181K in Q3 2020. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • HRT Financial reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • HRT Financial sold 57,533 PDL BioPharma, Inc. shares in Q4 2020, an estimated $181K.
  • HRT Financial first reported a position in PDL BioPharma, Inc. in Q2 2017 and held it in 2 quarters.
  • HRT Financial's PDL BioPharma, Inc. position peaked at $181K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.